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Abstract
Videocapillaroscopy is a noninvasive, quick, and easy examination method to indicate if 
there is clinical suspicion of microangiopathy. It provides the rheumatologist indispens‐
able information on the microcirculation state. Recently with the development of the new 
classification criteria of systemic sclerosis (ACR 2013), capillaroscopy has become even 
more important. It is currently the only instrumental test whose result is pathognomonic 
for diagnosis of systemic sclerosis. During videocapillaroscopy, the following param‐
eters are evaluated: density, structure, hemosiderin deposition, bloodstream, presence 
of megacapillaries, presence of subpapillary venous plexus, and edema. It can distin‐
guish several patterns, especially scleroderma pattern, as follows: (1) “Early” pattern: few 
enlarged/giant capillaries, few capillary hemorrhages, relatively well‐preserved capillary 
distribution, no evident loss of capillaries; (2) “Active” pattern: frequent giant capillaries, 
frequent capillary hemorrhages, moderate loss of capillaries, mild disorganization of the 
capillary architecture, absent or mild ramified capillaries; (3) “Late” pattern: irregular 
enlargement of the capillaries, few or absent giant capillaries and hemorrhages, severe 
loss of capillaries with extensive avascular areas, disorganization of the normal capil‐
lary array, ramified/bushy capillaries. Although capillaroscopic examination is easy to 
perform, it is essential that the operator has been properly trained on the instrument’s 
function and on correct method of image acquisition to avoid misinterpretation.
Keywords: nailfold capillaroscopy, Raynaud’s phenomenon, scleroderma pattern, prognostic 
score
1. Introduction
Capillaroscopy is a noninvasive, fast, and easy imaging technique to evaluate the assessment 
of the microcirculation. It is indicated in patients with suspect of microangiopatia [1].
It gives precise information about capillaries’ conditions and related diseases to rheumatologist.
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Recently, after the development of new systemic sclerosis classifications criteria [2], the role 
of capillaroscopy became more important. In fact a score of two out of nine is assigned in the 
case of significant capillaroscopic abnormalities to diagnose this disease (Table 1).
In the past, the study of capillaries was performed by instruments that could zoom, take pic‐
tures, or film the blood microcirculation, such as the ophthalmoscope and the dermatoscope, 
the stereo microscope, and tools for macrophotography.
The modern capillaroscopy, equipped with optical probes, is today commonly used in rheu‐
matological and dermatological practice, and it is able to zoom (magnificat) capillaries in 
order of 200×, obtaining much qualitative measurements that could be reproducible.
The instrument consists of an optical probe fitted with an adjustable magnification and illu‐
mination ring for focusing and a personal computer (with high resolution color screen) with 
software for data processing. Several new models interface with iOS or Android system, and 
they are more portable (Figure 1).
Although capillaroscopic examination is easy to perform, it is essential that the operator has 
been properly trained about the instrument’s functioning and correct method of image acqui‐
sition to avoid misinterpretation [3].
Table 1. Systemic sclerosis classification criteria 2013.
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2. The capillaroscopic technique
Capillaroscopy should be always performed in conditions of constant temperature. By con‐
vention, it is considered that the patient needs an acclimatization of at least 15 min at the 
temperature of 21–24°C before performing the examination.
When booking the videocapillaroscopy, it is necessary to give to the patient a few sugges‐
tions, especially to avoid the manicure in 7–10 days prior to the examination and application 
of nail polish.
At the time of the examination, the patient should be sat with his hands gently resting on the 
table on the palm with the fingers slightly apart.
Before starting the exam, it is necessary to apply a drop of oil (usually cedar oil) on the nail 
fold of each district that should be examined. At this level, the capillaries shall run parallel to 
the skin plane and, therefore, in normal subjects, are visible an afferent branch, a loop and an 
efferent branch (capillary hairpin).
Usually, they are investigated four districts in each hand leaving the first finger that usually 
has a bad view of the vascular widespread and nonspecific alterations. Furthermore, several 
studies have shown that, even in the presence of Raynaud phenomenon exclusively localized 
at the foot, capillaroscopy of the hands provides the same information that would be obtained 
by investigating the lower limbs and, therefore, for convenience, the examination, even in 
these cases, is usually performed exclusively in the hand level.
Modern software let you select on the monitor the investigation from time to time in the dis‐
trict, so you can compare any changes in respect of each finger. Also, they include measuring 
systems for dimensional analysis [4].
Figure 1. Example of Wi‐fi capillaroscope.
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Although there are some parameters to indicate a normal/healthy capillaroscopic, it is impor‐
tant to consider that there is great variability in the capillary structure both interindividual 
and intraindividual. This variability depends on many factors such as employment, racial, 
and environmental.
In particular, in patients underwent to repeated microtrauma for professional reasons, such 
as typists, jackhammer users, pianists, etc., it is not uncommon to observe widespread phe‐
nomena of microhemorrhages and neoangiogenesis. As well as, patients who smoke have 
often shortened and tortuous capillaries. Moreover, in patients with dark or very dark skin 
color (e.g., for racial factors), it is often difficult to correctly visualize the capillaries and almost 
impossible to see the subpapillary venous plexus. Modern capillaroscopies with editable light 
intensity solve this problem in part. It is also important that the capillaroscopic be set from 
time to time for each patient calibrating on the “contrast”, “range,” and “saturation” functions 
to obtain an image that is as clear as possible [5].
3. The capillaroscopic parameters in normal/healthy conditions
A good capillaroscopic examination is achieved by positioning the probe plumb to the 
district under consideration and to obtain the correct visualize of the dermal papilla 
roughly between the middle and the upper third of the monitor (photo 2—correct assess‐
ment of the image). The area of interest is in fact just the dermal papilla and the capil‐
laries residing there, or should reside within it, although the outside alterations are also 
important [6–8].
During capillaroscopy, the following parameters are evaluated:
• Density
• Structure
• Microhemorrhages
• Bloodstream
• Edema (soft focus effect)
• Subpapillary venous plexus
Density: In a healthy subject, the number of capillaries per millimeter is equal to 11 ± 2 while 
the number of capillaries for dermal papilla is equal to 2 ± 1 (picture 3: number of capillaries 
normal, equal to 12 per mm). The conditions under which this number is reduced may be 
described simply as “density reduction capillary” up to extreme situations of complete absence 
capillary describable as “areas avascular” or, in the case of a specific papilla, “vacuous papilla” 
(Figure 2: normal density; Figure 3: (a) and (b) area avascular papillary or “papillae vacuous.”)
Structure: The capillaries of the healthy subject, in most cases, have an aspect so‐called “hair‐
pin shape” or “U‐shaped” and are well aligned, in an orderly manner, the one beside the 
other with a “comb arrangement” (Figure 4: distribution capillary ordered to comb with 
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aspect hairpin), all similar in form and with some dimensional variability (length approxi‐
mately between 200 and 500 μm).
You can observe the modest structural disorganization even in healthy individuals. Instead, 
the complete subversion of it is attributable to pathological conditions.
They should not be present ramifications that often indicate a poor vascularization with 
angiogenesis to provide the blood supply of avascular areas.
Tortuosities are often found, for the most in apical zone, and the capillary has a distorted 
aspect. It manifested as single or multiple cross/overs and/or patterns described as “trefoil,” 
“antler,” “glomerular loop,” and “treble clef.” These anomalies can be isolated or diffuse 
(Figure 5: tortuosities).
The apical tortuosities, by themselves, are not a pathologic finding. They are frequently found 
in heavy smokers, in patients underwent to repeated microtrauma, in patients with psoriasis 
and in various other conditions.
Otherwise, the tortuosity can be contextualized within a framework frankly altered or a real 
scleroderma pattern.
Figure 2. Example of normal pattern.
Figure 3. (a) and (b) Black arrows indicate papillae vacuous.
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The capillary branches (afferent and efferent loop) of the healthy subject normally have a 
diameter between 8 and 20 μm depending on the capillary portion considered. In fact, usu‐
ally, the loop efferent, due to venous stasis, is slightly larger than that afferent.
They are defined “enlarged” capillaries with a diameter between 30 and 50 μm measured at 
the level of the two branches and the loop, “mega” capillaries with diameter >50 μm at the 
level of the two branches and the loop, and “giant” capillaries with diameters >100 μm wide 
and the two branches of the loop (Figure 6: megacapillaries and giant capillaries).
Morphostructural minor anomalies (e.g., tortuosity) are found in approximately 10–20% of 
healthy subjects.
Among irregularly enlarged capillaries, loop size can vary considerably in different segments, 
with normal portions alternating with extremely enlarged areas, sometimes giving a “micro‐
aneurysmatic” or “rosary‐like” appearance (Figure 7).
Microhemorrhages: Although the microhemorrhages are frequent elements in the pathologi‐
cal or scleroderma pattern, it is not uncommon to observe them in healthy individuals as a 
Figure 5. Tortuosity in apical zone.
Figure 4. Normal structure: hairpin shape.
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result of trauma. In these cases, bleeding is well‐defined, unique, and usually transient, not 
necessarily directly related to the underlying capillaries. It is also not uncommon to observe 
very distant from the papilla or much below it.
The extravasation blood of pathological capillaries assumes a characteristic aspect in the sup‐
ply chain “a strung pearls” (Figure 8a and b: microhemorrhages to “strung pearls”), or mold 
on the capillary (Figure 8c and d: “Napoleonic hat”).
It can get an idea more or less realistic age of bleeding based on the analysis of the same color 
that tends to move from dark red to light yellow before disappearing altogether.
In the case of disease patterns may be encountered persistent deposits hemosiderin standing.
Nailfold microbleeds may also be related to capillary thrombosis which can occur in some 
pathological conditions and is often misinterpreted as hemorrhages. A key distinguishing 
feature of capillary thrombosis is the configuration of the dark area, which mirrors that of the 
capillary loops.
Figure 6. (a) and (b) Megacapillaries and giant capillaries.
Figure 7. Capillaries with “rosary‐like” aspect.
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Bloodstream: The capillaroscopy is a dynamic examination and allows to study blood flow, 
although in an approximate manner when compared to the Doppler technique.
A capillary with continuous blood flow is normal index. It will appear constantly full, and 
in the case when pressure is exerted by the probe on the same papilla, these will quickly fill 
the cessation of the stimulus. In the case of slowed blood flow, this will assume a granular 
appearance in particular in correspondence of the capillary walls and, in the case a pressure 
is exerted with the capillaroscopic probe the capillary will fill up slowly to cease the stimulus.
In the case where there is capillary thrombosis, typical of giant capillaries or megacapillari, 
the flow will appear static, and neither the pressure exerted by the probe nor the subsequent 
stop of the stimulus will show variations in the capillary which will appear always full.
Edema (soft focus effect): The flou effect in photography is a special effect that is achieved by 
reducing the contrast of the image without really being blurred. In capillaroscopy, it is talking 
about flou effect when, at the subpapillary, capillaries appear poorly visible in an edematous 
context of vascular congestion.
Occasionally, it is seen in healthy subjects. Alone it does not constitute a significant fault 
(Figure 9: flou effect).
Subpapillary venous plexus: The plexus is visible in the case of good skin transparency and 
is best viewed in the extreme ages of life (Figure 10(a) and (b)).
The venous plexus vessels have a perpendicular progress to the capillaries and are larger.
Figure 8. (a) and (b) Microhemorrhages to “strung pearls”; (c) and (d) microhemorrhages to “Napoleonic hat.”
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In cases of serious and widespread destruction capillaries, such as in the advanced stages 
of systemic sclerosis, the subpapillary venous plexus may constitute the only identifiable 
vascular element.
In healthy individuals, it is not always detectable.
4. Capillaroscopy in pathologic subjects
4.1. Introduction
Secondary Raynaud’s phenomenon refers to the clinical manifestation in the presence of an 
underlying systemic disease.
Figure 9. Black arrow → indicates flou effect.
Figure 10. (a) and (b) Good visibility of the subpapillary venous plexus.
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Among the diseases of rheumatologic interest, the more strongly and inseparably linked to 
Raynaud’s phenomenon is the systemic sclerosis, even if this appears also in the presence of 
other autoimmune diseases such as systemic lupus erythematosus, dermatomyositis, undif‐
ferentiated connective, and mixed connective, in a small percentage of cases, in the presence 
of rheumatoid, psoriatic, or juvenile idiopathic arthritis.
Capillaroscopy does not constitute, in itself, a diagnostic test. Especially not usefull to diag‐
nostic Raynaud’s phenomenon, whose diagnosis is exclusively linked to the clinic. The exami‐
nation provides a specific view on the state of the microcirculation and in particular on its 
integrity and is always related to the clinical and laboratory data. Then we can determine 
whether the Raynaud’s phenomenon is referable to a damage of the microcirculation [8, 9].
However, capillaroscopy plays a key role in the diagnosis of connective tissue diseases and 
especially of the scleroderma spectrum disorders, which include, in addition to systemic scle‐
rosis, the dermatomyositis, the undifferentiated, and mixed connective tissue disease [10, 11].
In fact, historically, the typical capillaroscopic alterations for scleroderma spectrum disorders 
have always played a fundamental role in the diagnosis of systemic sclerosis, being included 
in all the diagnostic criteria formulated over the years for this condition, including the latest 
ACR criteria of 2013.
In contrast to what happens in the case of primitive Raynaud’s phenomenon, in the presence 
of secondary Raynaud’s phenomenon, the capillaroscopy is able to reveal specific anomalies.
Over the years, we have been implemented many efforts in an attempt to identify specific capilla‐
roscopic paintings for a specific pathology. These efforts have hesitated in identifying a capillaro‐
scopic pattern defined as “scleroderma pattern.” More than 95% of patients with overt systemic 
sclerosis have morphological markers of microvascular disorganization, including giant capillar‐
ies, microhemorrhages, loss of capillaries, avascular areas, and angiogenesis [12–14].
4.2. Systemic sclerosis
Specific capillaroscopic alterations are found in the majority of cases of systemic sclerosis and 
often several years before diagnosis. The key element that distinguishes the scleroderma pat‐
tern is megacapillare. Another common finding is typical microhemorrhage called “pearls 
strung” or “Napoleon hat” usually overlying dilated capillaries or megacapillaries. Third 
distinctive element is represented by avascular areas. In 2000, the group of Genoa, headed 
by professor Cutolo, has identified three types of scleroderma pattern, referred to as “early,” 
“active,” and “late” [15–17].
We analyze below a capillaroscopic examination as a “scleroderma pattern.”
Density: As is known in a healthy subject, the number of capillaries per millimeter is equal to 
11 ± 2 while the number of capillaries for dermal papilla is equal to 2 ± 1. In the case of sclero‐
derma, pattern is common to find a reduction in the number of capillaries. In particular, the 
reduction of the density can range from focused frameworks (e.g., to a single papilla “vacu‐
ous papilla”) to framework of rarefied widespread, until the total disappearance of capillaries 
with large subpapillary vascular areas. The most dramatic paintings are typical of late stages 
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or framework identified by Cutolo et al. as “late,” even if similar findings can be found in 
patients with recent symptoms onset, especially in progressive cases.
Structure: The most significant finding of scleroderma pattern, as said, is the megacapillare 
or a capillary which measures a greater diameter than 50 μm in correspondence with the 
two branches of the ascending and descending loops. In the case of diameters greater than 
100 μm, it is called the capillary giant. The presence of only one megacapillare within a nor‐
mal framework is not sufficient to define scleroderma pattern although suggests the need a 
follow up. The presence of two or more megacapillaries leads to a scleroderma pattern even 
in the absence of microhemorrhages or avascular areas.
Generally, the presence of megacapillari in the context of apparently normal capillaries, with 
few or absent microhemorrhages, characterizes the earliest stages of the disease and it is iden‐
tified by Cutolo et al. as “early.” Instead, in the presence of numerous or ubiquitous megacap‐
illari in the context of rare normal capillaries or ectatic capillaries, in the presence of numerous 
microhemorrhages in more districts, we will be faced to a capillary framework called “active.”
In the late stages of systemic sclerosis are sometimes pathognomonic capillary ramifications, 
with elongated and bizarre capillaries, or overgrowth of the subpapillary venous plexus, last 
attempt to make up for the total or almost total disappearance of the subpapillary capillaries. 
This framework configures the “late” scleroderma pattern.
Other detectable morphostructural abnormalities in scleroderma pattern are ectasia (capillaries 
in the range from 30 to 50 μm), the tortuosities, identifying, based on the forms as “staghorn,” 
“a clef,”“a glomerulus,”“ball,” etc. and microaneurysms. These alterations are not specific and 
can also be found in healthy subjects.
Microhemorrhages: They constitute an extremely common finding in the scleroderma pattern 
and, especially in the one called “active”. The typical hemorrhages of the scleroderma pattern 
may look as a mold, overlooking a megacapillare, or a giant capillary, or an aspect to “strung 
pearls” that are stacked in succession in the subpapillary and extrapapillary, never in deep 
seat. The microhemorrhages indicated breaking of capillary wall and are a sign of microvas‐
cular damage. There may be bleeding in the absence of megacapillari. The lonely bleeding are 
not considered sufficient for the identification of scleroderma pattern although, the presence of 
diffuse bleeding, even in the absence of further alterations, suggests necessarily the follow up.
The microhemorrhages should not be confused with traumatic hemorrhages that have a very 
heterogeneous presentation, generally overlying or adjacent to completely normal capillaries. 
Usually, they have a greater extension and can be found in the subpapillary‐, deep‐or extra‐
papillary segment.
Flow: The typical flow scleroderma patterns abnormalities are linked to the structural dam‐
age, in particular to megacapillaries. In these cases, the blood flow can appear slow or granu‐
lar or even static. In the case of slow or static flow, a stimulus as the modest pressure exercised 
by the capillaroscopy probe is sufficient to make empty capillaries, and the capillaries will 
become fills when pressure is stopped. However, megacapillaries, giant capillaries, and the 
microaneurismatic capillaries remain completely filled both in the presence and in the absence 
of pressure stimulus, indicating a wall thickening causing static flow.
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Edema (soft focus effect): Subpapillary edema is a constant finding in the case of capillaries 
vasodilatation in particular in the presence of megacapillaries and giant capillaries, so it is a 
typical finding in the scleroderma pattern. Edema could be mild, moderate, or severe and in 
these cases, subpapillary nous plexus is hardly visible.
Subpapillary venous plexus: It is clearly visible in healthy subjects and the extreme ages of 
life, can be seen in the case of early scleroderma pattern, is usually barely visible or not visible 
in the “active” phase, and is the only detectable findings in the late stage, where papillary 
capillaries are absent. Bizarre capillary ramifications are frequent findings in the late stage, as 
a last attempt to overcome the vascular deficit.
Scleroderma pattern:
• Early scleroderma pattern (Figure 11(a–c)): framework characterized by the presence of 
dilated capillaries and some megacapillaries. Microhemorrhages are poorly represented or 
absent. No reduction in capillary density.
• Active scleroderma pattern (Figure 12(a) and (b): framework characterized by the wide‐
spread presence of megacapillaries and/or giant capillaries. A large number of microhem‐
orrhages. No reduction in capillary density or occasional finding of “papilla vacua” in the 
presence of angiogenesis phenomena.
• Late scleroderma pattern (Figure 13(a) and (b): framework characterized by the presence 
of rare lasts megacapillaries, abundant ramifications. Rare or absent microhemorrhages. 
Large avascular areas. Exuberance of the subpapillary venous plexus.
Figure 12. (a) and (b) Diffuse megacapillaries with microhemorrhages.
Figure 11. (a–c) Few megacapillaries without microhemorrhages.
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5. Capillaroscopy in other rheumatic diseases
As mentioned, all of rheumatic diseases included in the scleroderma spectrum disorders may 
present a capillaroscopic framework suggesting for scleroderma pattern. However, in some 
diseases, there are typical capillary feature presentations. For example, in rheumatoid arthri‐
tis, extremely elongated capillaries are the principal findings (Figure 14) [18, 19].
In dermatomyositis, the most frequent findings are dilated and giant capillaries with tree‐like 
appearance (Figure 15(a) and (b)).
Even in the case of psoriatic arthritis, capillaries appear rather short and stubby (Figure 16).
However, these features are not enough specific to identify a defined framework.
5.1. Scoring method
In present‐day clinical practice, capillaroscopic surveys are usually analyzed qualitatively in 
order to show patterns of disease (as previously stated). However, some authors share the 
idea that a normalization of the capillaroscopic pattern may be positive.
Figure 13. (a) and (b) “Papilla vacua,” diffuse or localized loss of capillaries.
Figure 14. Capillaroscopy in rheumatoid arthritis.
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Different scoring methods have been proposed to prospectively evaluate both the trend and 
the gravity of the scleroderma microangiopathy.
5.2. Semiquantitative method
One of these methods is the semiquantitative assessment which contemplates the analysis of 
the following capillaroscopic parameters:
1. Loss of capillaries: reduction of the number of capillaries to less than 9 per mm
2. Disorganization of the capillary architecture: irregular loops distribution, orientation, and 
morphology
3. Tree‐like capillary network: capillaries with skein‐like or shrub‐like branched loops.
Figure 15. (a) and (b) Tree pattern in dermatomyositis.
Figure 16. Capillaroscopy pattern in psoriatic arthritis.
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Each parameter is given a score based on the given impairment:
• 0: no alteration
• 1: capillary impairment up to 33%
• 2: capillary impairment higher than 33% and up to 66%
• 3: capillary impairment higher than 66%
The average score for each parameter comes from the analysis of four conterminous capil‐
laroscopic areas (each area consisting of a 1 mm2 surface) in the central part of the II, III, IV, 
and V finger of each hand.
The final score of each parameter is given by adding up the average scores of each finger; then 
the result is divided by 8. Lastly, the sum of the three scores constitutes the microangiopathy 
evolution score whose value may vary from 0 to 9.
On the basis of the capillaries loss only, such score is easier to determine and has been pro‐
posed as a predictor of digital ulcers. An average score of the capillaries number decrease 
is obtained by using capillary density as only parameter if a 1 mm2 surface on eight fingers 
is analyzed. Scores that appear to be higher than 1.67 are shown to be a predictive factor 
of digital ulcers (Se 70%, Sp 69.77%, with a positive likelihood ratio of 2.32 and a negative 
likelihood ratio of 0.43) since such ulcers occur within 6–12 months after the capillaroscopic 
evaluation [20] (Figure 17).
5.3. Quantitative method
This method needs a strict standardization to be reproducible and comparable through time. 
As of today, the only quantitative score to be validated for both replicabilities and the pre‐
dictive value is the Capillaroscopy Skin Ulcer Risk Index (CSURI), which is predictive for the 
incoming appearance of digital ulcers (which are already present within 3 months of the capil‐
laroscopy) and for the nonfulfillment of their recovery (Se 92.3%, Sp 81.4 %, NPV 97.2%, TPV 
84.3% with a PPV higher than 81% in the subgroup of patients with a history of ulcers appeared 
within a year).
The calculation is carried out by analyzing the whole nailfold area (from the II to the V finger 
of each hand, saving at least an image for each finger). Of all selected images, the one with the 
highest number of capillaries and the one with the lowest number of megacapillaries are to be 
considered; then the following formula has to be used: M×DN2 (with M: numbers of capillaries, 
D: maximum diameter, N: numbers of megacapillaries). Having at least a visible capillary is 
a prerequisite (otherwise the formula would be equal to 0; in fact, it is not possible to use it in 
5% of patients. In this case, the formula is considered positive in principle). The analyzed area 
must be 1.57 mm wide. CSURI calculation is based on one image chosen between the saved 
one (the image with the lowest number of capillaries should be preferred) (Figures 18 and 19).
Capillaroscopic parameters are defined in a strict way so that reproducibility and replicability 
are optimized:
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• Number of capillaries: all the capillaries in the first row (the ones closest to the papilla) 
must be counted even if they are all different depths.
• Megacapillary: maximum measurable diameter in the first row (microaneurysms should 
not be included).
• Tree‐like morphology: a tree‐like capillary is equivalent to the number of taken papillae or 
to the number of observable loops.
Figure 17. Number of fields studied: gold standard (F32) and successive simplifications (F16‐F8‐F4). (A) F32: eight 
fingers (arrows), four fields of 1 mm per finger, giving a total of 32 fields. (B) F16: eight fingers (arrows), two fields of 1 
mm per finger, giving a total of 16 fields. (C) F8: eight fingers (arrows), one filed of 1 mm per finger, giving a total of eight 
fields. (D) F4: one finger (arrows), four fields of 1 mm in that finger, giving a total of four fields [20].
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Figure 18. Examples of capillaroscopic finding measurements. (A) 4 capillaries, 3 giant capillaries (1 ramified giant 
capillaries occupying both dermal papillae). (B) 8 capillaries, 5 giant capillaries (every capillary was counted in the distal 
row even if it was not on the same level). (C) 13 capillaries, 1 giant capillary (1 ramified giant capillary computed as 2 
in the total number count). (D) 12 capillaries, 1 giant capillaries (every capillary was counted in the distal row even if it 
was not on the same level) [14].
Figure 19. Algorithm for capillaroscopic skin ulcer risk index (CSURI) evaluation. D, Maximum diameter of mega 
capillary; M, number of megacapillaries (diameter ≥ 50 μm); N, number of capillaries [14].
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The CSURI value per patient is the maximum computable if the whole nailfold area is ana‐
lyzed so that the highest score of microangiopathy is defined. PROs: number of false nega‐
tives <3%. CONs: a higher risk of increasing the false positives.[21].
5.4. Prognostic index
The Prognostic Index for Nailfold Capillaroscopic Examination (PRINCE: Table 2) allows to strat‐
ify the risk of development of a scleroderma spectrum disorder over a period of 5 years in 
Table 2. Prognostic parameters of PRINCE index.
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patients with Raynaud syndrome by analyzing the three main capillaroscopic anomalies 
(with the survey of a 1 mm area per finger):
• Presence of megacapillaries
• Presence of microhemorrhages
• Numbers of capillaries per mm
The inclusion of antinuclear antibodies allowed to develop an additional predictive model 
with the following risk categories: high (50+ %), medium (10–50%) and low risk (<10%) 
(Figure 20) [22].
Figure 20. Prognostic Index for Nailfold Capillaroscopic Examination (PRINCE). A, D, G, and J: possible combination 
of giant loops and microhemorrhages (0 = absent, 1 = present). The score (on the y‐axis) is obtained as a function of the 
number of capillaries (represented on the x‐axis). B, E, H, and K: data used with the corresponding scores in A, D, G, and 
J to obtain the incidence and thus deduce the risk of developing Raynaud’s phenomenon secondary to a scleroderma 
spectrum disorder. C, F, I, and L: examples of capillaroscopic patterns [22].
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6. The role of capillaroscopy in the early diagnosis of systemic sclerosis
The role of capillaroscopy has been considered over the years more and more attention, espe‐
cially in the early diagnosis of systemic sclerosis. Then, to detect valid predictors of early sys‐
temic sclerosis, the European Scleroderma Trials and Research group (EUSTAR) identified three 
red flags, thanks to the VEDOSS program (very early diagnosis of systemic sclerosis): Raynaud’s 
phenomenon (RP), antinuclear antibodies (ANA) positivity, and puffy fingers are the main ele‐
ments to suspect systemic sclerosis. In the case of these three flags performing, further tests 
to confirm the diagnosis, in particular nailfold video‐capillaroscopy and evaluation of specific 
disease antibodies (anticentromere and antitopoisomerase I), are mandatory. The challenge of 
VEDOSS program is to identify patients who will develop an established systemic sclerosis.
Very recently, the first results of the VEDOSS project were processed and new EULAR/ACR 
(American College of Rheumatology) classification criteria have been validated and pub‐
lished (2013), in which the capillaroscopic characteristic changes have been included (requir‐
ing at least two, or better, all four items to be present) (Figure 21) [23, 24].
7. Conclusions
Capillaroscopy is an easily tolerable, noninvasive, important angiologic examination 
method. In the case of Raynaud’s phenomenon, associated or not with signs or symptoms 
Figure 21. A behavioral flow chart for patients in whom the very early diagnosis of systemic sclerosis (SSc) should be 
considered is proposed. Red flags should trigger the differential diagnosis of SSc and guide the general practitioner to 
send the patient to the referral center where capillaroscopy and specific autoantibodies are ordered and the diagnosis of 
very early SSc is made. HRCT, high resolution CT; PFT, pulmonary function tests [23].
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suggestive for connective tissue disorders or in the presence of autoantibodies (in particu‐
lar, antinuclear antibodies (ANA) and extractable nuclear antigens (ENA)), capillaroscopy 
is a crucial examination that adds irreplaceable information to formulate a diagnosis. In 
the meantime, capillaroscopy has achieved a firm status in the early diagnosis of systemic 
sclerosis (SSc).
7.1. Capillaroscopic template
The report should include capillaroscopic terms understandable to nonexperts and should 
be as standardized as possible, using both qualitative and quantitative parameters that reli‐
able and establishing normal limits (Figure 22). In the presence of capillaroscopic, more 
alterations (megacapillaries, microhemorrhages, neoangiogenesis, density decrease,) a 
greater degree of detail is required, indicating although these alterations are present on only 
one or a few fingers.
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Figure 22. Example of Capillaroscopic Template.
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